Steven Gex
Chief Executive Officer
Implantable tissue marking device for surgery
Focal Therapeutics, Inc.
United States of America
Biography
An accomplished leader of several medical-device companies in women’s healthcare, Mr. Gex previously served as Chairman and CEO of BioLucent, Inc., manufacturer of the MammoPad® breast cushion to reduce mammography discomfort, which was acquired in September 2007 by Hologic, Inc. Prior to BioLucent, Mr. Gex co-founded and served as President and CEO of Biopsys Medical, Inc., the maker of Mammotome®, a non-surgical breast biopsy device used to diagnose breast cancer. At Biopsys, Mr. Gex guided the company’s initial public offering and subsequent sale to Johnson & Johnson in 1997. He has also served on the boards of directors for several other medical device companies such as Opus Medical, VivaRay, Cianna Medical and Cayenne Medical. Mr. Gex received a B.S. in Business Marketing from San Diego State University.
Research Interest
Implantable device, radiographic marking of sites in soft tissue for future medical procedures